-
21
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
22
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
23
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
24
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
25
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
26
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
27
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
28
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
29
A telemedicine triage model for infusion center–based management of adult sickle cell pain episodes
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
30
-
31
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
32
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
33
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
34
Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
35
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
36
The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
37
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
38
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
39
Mehta RS, Ramdial J, Kebriaei P, et al. Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024;8(20):5306-...
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
40
Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
Published 2025-01-01“…Blood Advances…”
Get full text
Article